Browse 24839 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 24th, 2020 |
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 24th, 2020 |
BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2021 |
High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2022 |
Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2022 |
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
November 7th, 2018 |
FY 2019 RSVP Competition |
Corporation for National and Community Service |
October 4th, 2018 |
Quality Health Intiative |
Mozambique USAID Maputo |
November 21st, 2018 |
Research Centers in Minority Institutions (RCMI) (U54)- Clinical Trials Optional |
National Institutes of Health |
September 5th, 2021 |
Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
November 18th, 2018 |
Strengthen Cameroon's National Tuberculosis Control Program (NTCP) to Decrease the TB/HIV Burden and Develop Systems to Achieve and Sustain TB/HIV Epidemic Control in Cameroon under the President's Emergency Plan for |
Centers for Disease Control CGH |
November 12th, 2019 |
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 12th, 2020 |
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
December 5th, 2018 |
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) |
National Institutes of Health |
November 29th, 2018 |
Responding to Opioid Use Disorders (OUD) in Tribal Communities in the Context of SAMHSA and CDC Funding (R61/R33 - Clinical Trials Optional) |
National Institutes of Health |
May 6th, 2019 |
Announcement of Availability of Funds for Data Analysis and Trends Research Grants |
Office of the Assistant Secretary for Health |
November 7th, 2018 |
FY 2019 RSVP Competition |
Corporation for National and Community Service |
September 5th, 2021 |
Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
December 11th, 2018 |
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Data Coordinating Center) (UM1 - Clinical Trials Not Allowed) |
National Institutes of Health |
December 11th, 2018 |
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis (Research Sites) (UM1 - Clinical Trial Required) |
National Institutes of Health |
November 12th, 2019 |
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
|
December 14th, 2018 |
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
December 14th, 2018 |
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R41/R42 - Clinical Trial Optional) |
National Institutes of Health |
April 1st, 2021 |
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp) |
National Institutes of Health |
March 19th, 2019 |
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional) |
National Institutes of Health |
November 20th, 2018 |
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center (U24 Clinical Trial Optional) |
National Institutes of Health |
November 20th, 2018 |
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers (U01 Clinical Trial Required) |
National Institutes of Health |
November 20th, 2018 |
Identification, Surveillance, and Control of Vector-Borne and Zoonotic Infectious Diseases in Uganda |
Centers for Disease Control and Prevention ERA |
January 14th, 2021 |
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
November 1st, 2019 |
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required) |
National Institutes of Health |
October 22nd, 2018 |
Expanding Access to Evidence-Based Voluntary Drug Demand Reduction Program in the Philippines |
Philippines USAID Manila |
March 19th, 2019 |
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional) |
National Institutes of Health |
February 22nd, 2019 |
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) |
National Institutes of Health |
November 15th, 2018 |
Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required) |
National Institutes of Health |
November 15th, 2018 |
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) |
National Institutes of Health |
November 14th, 2018 |
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
November 14th, 2018 |
Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Research Sites (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 14th, 2018 |
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Tissue and Technology Core (TATC) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
September 21st, 2018 |
Competitive Cooperative Agreement Solicitation Combating Opioid Overdose through Community-Level Intervention |
Office of National Drug Control Policy |
November 14th, 2018 |
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Data Coordinating Core (DCC) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
November 14th, 2018 |
Limited Competition for the Continuation of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Discovery Sites (U01 Clinical Trial Not Allowed) |
National Institutes of Health |